<DOC>
	<DOCNO>NCT00793910</DOCNO>
	<brief_summary>The purpose study determine effectiveness oral medication call gabapentin reduce pain Photorefractive Keratectomy ( PRK ) eye surgery ass frequency use rescue medication intervention , define non-steroidal anti-inflammatory ( NSAID ) eye drop oral narcotic medication .</brief_summary>
	<brief_title>Oral Gabapentin Versus Placebo Treatment Postoperative Pain Following Photorefractive Keratectomy</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>Ability understand provide inform consent participate study complete followup visit . Planned Photorefractive keratectomy ( PRK ) WRAMC Center Refractive Surgery . Male female , race , least 21 year old time preoperative examination , sign informed consent . The low age limit 21 year intend ensure documentation refractive stability . Access transportation meet followup requirement . Any reason exclude PRK . Female subject pregnant , breast feeding intend become pregnant study . Female subject give urine pregnancy test prior participate study rule pregnancy . [ Pregnancy breastfeed contraindication refractive surgery general , include PRK , whether participate study ] . Patients know allergy , sensitivity inappropriate responsiveness Gabapentin medication use postoperative course . Patients know depressed renal function . Any physical mental impairment would preclude participation examination .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Gabapentin</keyword>
	<keyword>PRK</keyword>
	<keyword>pain</keyword>
</DOC>